Vanguard Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-769,761
| Closed | -$91.1M | – | 4502 |
|
|
2021
Q1 | $91.1M | Buy |
769,761
+22,696
| +3% | +$2.68M | ﹤0.01% | 2000 |
|
|
2020
Q4 | $88.2M | Sell |
747,065
-94,252
| -11% | -$10.9M | ﹤0.01% | 1895 |
|
|
2020
Q3 | $93.5M | Sell |
841,317
-69,091
| -8% | -$7.42M | ﹤0.01% | 1717 |
|
|
2020
Q2 | $93M | Sell |
910,408
-82,235
| -8% | -$8.8M | ﹤0.01% | 1718 |
|
|
2020
Q1 | $107M | Buy |
992,643
+48,052
| +5% | +$5.52M | ﹤0.01% | 1489 |
|
|
2019
Q4 | $110M | Buy |
944,591
+43,921
| +5% | +$5.09M | ﹤0.01% | 1700 |
|
|
2019
Q3 | $103M | Sell |
900,670
-49,751
| -5% | -$4.95M | ﹤0.01% | 1709 |
|
|
2019
Q2 | $90.6M | Buy |
950,421
+29,178
| +3% | +$2.75M | ﹤0.01% | 1803 |
|
|
2019
Q1 | $84.1M | Buy |
921,243
+21,651
| +2% | +$1.77M | ﹤0.01% | 1836 |
|
|
2018
Q4 | $68.3M | Buy |
899,592
+26,040
| +3% | +$1.92M | ﹤0.01% | 1871 |
|
|
2018
Q3 | $69.9M | Buy |
873,552
+90,532
| +12% | +$8.44M | ﹤0.01% | 1981 |
|
|
2018
Q2 | $77.8M | Buy |
783,020
+70,776
| +10% | +$6.12M | ﹤0.01% | 1895 |
|
|
2018
Q1 | $57.7M | Buy |
712,244
+12,616
| +2% | +$1.02M | ﹤0.01% | 2000 |
|
|
2017
Q4 | $55.1M | Buy |
699,628
+162,995
| +30% | +$13.6M | ﹤0.01% | 2013 |
|
|
2017
Q3 | $49.5M | Buy |
536,633
+512,947
| +2,166% | +$49.3M | ﹤0.01% | 2048 |
|
|
2017
Q2 | $2.68M | Buy |
23,686
+19,169
| +424% | +$2.14M | ﹤0.01% | 3293 |
|
|
2017
Q1 | $452K | Hold |
4,517
| – | – | ﹤0.01% | 3776 |
|
|
2016
Q4 | $486K | Buy |
4,517
+17
| +0.4% | +$1.99K | ﹤0.01% | 3741 |
|
|
2016
Q3 | $560K | Hold |
4,500
| – | – | ﹤0.01% | 3738 |
|
|
2016
Q2 | $478K | Hold |
4,500
| – | – | ﹤0.01% | 3806 |
|
|
2016
Q1 | $515K | Buy |
4,500
+1,000
| +29% | +$117K | ﹤0.01% | 3785 |
|
|
2015
Q4 | $499K | Hold |
3,500
| – | – | ﹤0.01% | 3833 |
|
|
2015
Q3 | $314K | Buy |
+3,500
| New | +$369K | ﹤0.01% | 3958 |
|
Vanguard Group's CBPO Position: Q2 2021 in Review
Vanguard Group sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 769,761 shares — an estimated $91.1M sold.
Vanguard Group first reported a position in CBPO in Q3 2015 and held it in 23 quarters. The position peaked at $110M in Q4 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Vanguard Group reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Vanguard Group sold 769,761 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $91.1M.
- Vanguard Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 23 quarters.
- Vanguard Group's China Biologic Products Holdings, Inc. position peaked at $110M in Q4 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Vanguard Group's 13F filing for Q2 2021, filed 13 Aug 2021.